ID
45930
Description
The general purpose of this trial is to investigate the efficacy and safety of 4 dose strategies of BIBF 1120 treatment for 12 months, compared to placebo in patients with idiopathic pulmonary fibrosis. The primary objective of this study is to demonstrate whether at least one dose strategy is superior to placebo in patients with IPF, in modifying the rate of decline of Forced Vital Capacity (FVC). As a secondary objective, additional parameters will be assessed in order to differentiate between dose strategies on the basis of safety and efficacy
Link
Keywords
Versions (3)
- 3/5/24 3/5/24 - Dr. Christian Niklas
- 3/28/24 3/28/24 - Dr. Christian Niklas
- 3/28/24 3/28/24 - Dr. Christian Niklas
Copyright Holder
Boehringer Ingelheim
Uploaded on
March 5, 2024
DOI
To request one please log in.
License
Creative Commons BY-NC-SA 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Safety And Efficacy of BIBF 1120 in Idiopathic Pulmonary Fibrosis
AE
- StudyEvent: CUM_AE
- StudyEvent: CUM_CT
- StudyEvent: TRT CHANGE
- StudyEvent: IVRS
- StudyEvent: VISIT 1
- StudyEvent: VISIT 2
- StudyEvent: VISIT 3
- StudyEvent: VISIT 4
- StudyEvent: VISIT 5
- StudyEvent: VISIT 6
- StudyEvent: VISIT 6A
- StudyEvent: VISIT 7
- StudyEvent: VISIT 7A
- StudyEvent: VISIT 8
- StudyEvent: VISIT 8A
- StudyEvent: VISIT 9
- StudyEvent: END TRT 1
- StudyEvent: VISIT 10
- StudyEvent: VISIT 11
- StudyEvent: VISIT 12
- StudyEvent: VISIT 12A
- StudyEvent: VISIT 13
- StudyEvent: VISIT 13A
- StudyEvent: VISIT 13B
- StudyEvent: VISIT 13C
- StudyEvent: VISIT 14
- StudyEvent: VISIT 14A
- StudyEvent: VISIT 14B
- StudyEvent: VISIT 14C
- StudyEvent: VISIT 15
- StudyEvent: VISIT 15A
- StudyEvent: VISIT 15B
- StudyEvent: VISIT 15C
- StudyEvent: VISIT 16
- StudyEvent: VISIT 16A
- StudyEvent: VISIT 16B
- StudyEvent: VISIT 16C
- StudyEvent: END TRT 2
- StudyEvent: EOT
- StudyEvent: FOLLOWUP
- StudyEvent: DISC V4
- StudyEvent: DISC V5
- StudyEvent: DISC V6
- StudyEvent: DISC V7
- StudyEvent: DISC V8
- StudyEvent: DISC V9
- StudyEvent: COMPLETION
Similar models
AE
- StudyEvent: CUM_AE
- StudyEvent: CUM_CT
- StudyEvent: TRT CHANGE
- StudyEvent: IVRS
- StudyEvent: VISIT 1
- StudyEvent: VISIT 2
- StudyEvent: VISIT 3
- StudyEvent: VISIT 4
- StudyEvent: VISIT 5
- StudyEvent: VISIT 6
- StudyEvent: VISIT 6A
- StudyEvent: VISIT 7
- StudyEvent: VISIT 7A
- StudyEvent: VISIT 8
- StudyEvent: VISIT 8A
- StudyEvent: VISIT 9
- StudyEvent: END TRT 1
- StudyEvent: VISIT 10
- StudyEvent: VISIT 11
- StudyEvent: VISIT 12
- StudyEvent: VISIT 12A
- StudyEvent: VISIT 13
- StudyEvent: VISIT 13A
- StudyEvent: VISIT 13B
- StudyEvent: VISIT 13C
- StudyEvent: VISIT 14
- StudyEvent: VISIT 14A
- StudyEvent: VISIT 14B
- StudyEvent: VISIT 14C
- StudyEvent: VISIT 15
- StudyEvent: VISIT 15A
- StudyEvent: VISIT 15B
- StudyEvent: VISIT 15C
- StudyEvent: VISIT 16
- StudyEvent: VISIT 16A
- StudyEvent: VISIT 16B
- StudyEvent: VISIT 16C
- StudyEvent: END TRT 2
- StudyEvent: EOT
- StudyEvent: FOLLOWUP
- StudyEvent: DISC V4
- StudyEvent: DISC V5
- StudyEvent: DISC V6
- StudyEvent: DISC V7
- StudyEvent: DISC V8
- StudyEvent: DISC V9
- StudyEvent: COMPLETION
C0022877 (UMLS CUI [2,1])
C1514721 (UMLS CUI [2,2])
C1515021 (UMLS CUI [2,3])
C0441471 (UMLS CUI [1,2])
C0750502 (UMLS CUI [1,2])
No comments